AbCellera Biologics Inc.
US ˙ NasdaqGS ˙ CA00288U1066

SecurityABCL / AbCellera Biologics Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,361,105 shares
Latest Disclosed Value $ 4,750,256
Citadel Advisors Llc ownership in ABCL / AbCellera Biologics Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,361,105 shares of AbCellera Biologics Inc. (US:ABCL) valued at $4,750,256 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,834,508 shares of AbCellera Biologics Inc.. This represents a change in shares of -25.81% during the quarter. The current value of the position is $7,649,410 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (ABCL) in the form of stock options. The firm currently holds call options representing 429,500 of underlying shares valued at $1,498,955 USD and put options representing 87,200 of underlying shares valued at $304,328 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ABCL / AbCellera Biologics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,361,105 -473,403 -25.81 4,750 -24.29 0.0008
2026-02-17 2025-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,834,508 825,893 81.88 6,274 23.67 0.0009
2025-11-14 2025-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 1,008,615 -1,881,145 -65.10 5,073 -48.81 0.0008
2025-08-14 2025-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 2,889,760 1,075,286 59.26 9,912 144.96 0.0017
2025-05-15 2025-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,814,474 1,217,223 203.80 4,046 131.33 0.0008
2025-02-14 2024-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 597,251 -902,389 -60.17 1,750 -55.14 0.0003
2024-11-14 2024-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 1,499,640 26,430 1.79 3,899 -10.57 0.0008
2024-08-14 2024-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 1,473,210 708,377 92.62 4,361 25.87 0.0009
2024-05-15 2024-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 764,833 186,527 32.25 3,465 4.91 0.0007
2024-02-14 2023-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 578,306 -171,425 -22.86 3,302 -4.23 0.0007
2023-11-14 2023-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 749,731 -1,444,039 -65.82 3,449 -75.67 0.0007
2023-08-14 2023-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 2,193,770 719,890 48.84 14,172 27.52 0.0029
2023-05-15 2023-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,473,880 8,884 0.61 11,113 -25.11 0.0024
2023-02-14 2022-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,464,996 968,448 195.04 14,840 202.18 0.0035
2022-11-14 2022-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 496,548 329,348 196.98 4,911 175.74 0.0011
2022-08-15 2022-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 167,200 -1,942 -1.15 1,781 8.00 0.0005
2022-05-16 2022-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 169,142 -248,948 -59.54 1,649 -72.42 0.0003
2022-02-14 2021-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 418,090 57,471 15.94 5,979 -17.27 0.0012
2021-11-15 2021-09-30 13F ABCELLERA BIOLOGICS Cmn 00288U106 360,619 -42,990 -10.65 7,227 -18.61 0.0015
2021-08-16 2021-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 403,609 263,034 187.11 8,879 85.99 0.0020
2021-05-21 2021-03-31 13F/A-1 ABCELLERA BIOLOGICS COM 00288U106 140,575 -291,782 -67.49 4,774 -72.56 0.0012
2021-05-17 2021-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 140,575 -291,782 4,774 0.0012
2021-02-16 2020-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 432,357 432,357 17,398 0.0045
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ABCELLERA BIOLOGICS COM Call 429,500 93.47 1,499 97.36 n/a n/a n/a
2026-02-17 2025-12-31 13F ABCELLERA BIOLOGICS COM Call 222,000 -6.45 759 -36.38 n/a n/a n/a
2025-11-14 2025-09-30 13F ABCELLERA BIOLOGICS COM Call 237,300 527.78 1,194 824.81 n/a n/a n/a
2025-08-14 2025-06-30 13F ABCELLERA BIOLOGICS COM Call 37,800 60.85 130 148.08 n/a n/a n/a
2025-05-15 2025-03-31 13F ABCELLERA BIOLOGICS COM Call 23,500 -80.86 52 -85.52 n/a n/a n/a
2025-02-14 2024-12-31 13F ABCELLERA BIOLOGICS COM Call 122,800 78.49 360 101.69 n/a n/a n/a
2024-11-14 2024-09-30 13F ABCELLERA BIOLOGICS COM Call 68,800 121.22 179 93.48 n/a n/a n/a
2024-08-14 2024-06-30 13F ABCELLERA BIOLOGICS COM Call 31,100 -4.31 92 -37.41 n/a n/a n/a
2024-05-15 2024-03-31 13F ABCELLERA BIOLOGICS COM Call 32,500 -89.56 147 -91.72 n/a n/a n/a
2024-02-14 2023-12-31 13F ABCELLERA BIOLOGICS COM Call 311,200 -11.06 1,777 10.38 n/a n/a n/a
2023-11-14 2023-09-30 13F ABCELLERA BIOLOGICS COM Call 349,900 18.97 1,610 -15.27 n/a n/a n/a
2023-08-14 2023-06-30 13F ABCELLERA BIOLOGICS COM Call 294,100 -5.37 1,900 -18.95 n/a n/a n/a
2023-05-15 2023-03-31 13F ABCELLERA BIOLOGICS COM Call 310,800 -13.95 2,343 -35.95 n/a n/a n/a
2023-02-14 2022-12-31 13F ABCELLERA BIOLOGICS COM Call 361,200 -9.72 3,659 -7.56 n/a n/a n/a
2022-11-14 2022-09-30 13F ABCELLERA BIOLOGICS COM Call 400,100 9.65 3,957 1.83 n/a n/a n/a
2022-08-15 2022-06-30 13F ABCELLERA BIOLOGICS COM Call 364,900 86.36 3,886 103.56 n/a n/a n/a
2022-05-16 2022-03-31 13F ABCELLERA BIOLOGICS COM Call 195,800 -27.96 1,909 -50.89 n/a n/a n/a
2022-02-14 2021-12-31 13F ABCELLERA BIOLOGICS COM Call 271,800 12.22 3,887 -19.92 n/a n/a n/a
2021-11-15 2021-09-30 13F ABCELLERA BIOLOGICS Cmn Call 242,200 31.92 4,854 20.18 n/a n/a n/a
2021-08-16 2021-06-30 13F ABCELLERA BIOLOGICS COM Call 183,600 287.34 4,039 150.87 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ABCELLERA BIOLOGICS COM Call 47,400 1,610 n/a n/a n/a
2021-05-17 2021-03-31 13F ABCELLERA BIOLOGICS COM Call 47,400 1,610 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ABCELLERA BIOLOGICS COM Put 87,200 -50.20 304 -49.16 n/a n/a n/a
2026-02-17 2025-12-31 13F ABCELLERA BIOLOGICS COM Put 175,100 -25.93 599 -49.71 n/a n/a n/a
2025-11-14 2025-09-30 13F ABCELLERA BIOLOGICS COM Put 236,400 -2.72 1,189 42.74 n/a n/a n/a
2025-08-14 2025-06-30 13F ABCELLERA BIOLOGICS COM Put 243,000 43.62 833 120.95 n/a n/a n/a
2025-05-15 2025-03-31 13F ABCELLERA BIOLOGICS COM Put 169,200 -1.74 377 -25.20 n/a n/a n/a
2025-02-14 2024-12-31 13F ABCELLERA BIOLOGICS COM Put 172,200 75.18 505 97.65 n/a n/a n/a
2024-11-14 2024-09-30 13F ABCELLERA BIOLOGICS COM Put 98,300 49.85 256 31.44 n/a n/a n/a
2024-08-14 2024-06-30 13F ABCELLERA BIOLOGICS COM Put 65,600 -14.69 194 -44.25 n/a n/a n/a
2024-05-15 2024-03-31 13F ABCELLERA BIOLOGICS COM Put 76,900 -41.12 348 -53.29 n/a n/a n/a
2024-02-14 2023-12-31 13F ABCELLERA BIOLOGICS COM Put 130,600 62.03 746 101.35 n/a n/a n/a
2023-11-14 2023-09-30 13F ABCELLERA BIOLOGICS COM Put 80,600 7.32 371 -23.71 n/a n/a n/a
2023-08-14 2023-06-30 13F ABCELLERA BIOLOGICS COM Put 75,100 5.33 485 -9.68 n/a n/a n/a
2023-05-15 2023-03-31 13F ABCELLERA BIOLOGICS COM Put 71,300 -64.08 538 -73.28 n/a n/a n/a
2023-02-14 2022-12-31 13F ABCELLERA BIOLOGICS COM Put 198,500 -9.36 2,011 -7.20 n/a n/a n/a
2022-11-14 2022-09-30 13F ABCELLERA BIOLOGICS COM Put 219,000 -25.36 2,166 -30.69 n/a n/a n/a
2022-08-15 2022-06-30 13F ABCELLERA BIOLOGICS COM Put 293,400 216.85 3,125 246.07 n/a n/a n/a
2022-05-16 2022-03-31 13F ABCELLERA BIOLOGICS COM Put 92,600 23.14 903 -16.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ABCELLERA BIOLOGICS COM Put 75,200 -36.54 1,075 -54.74 n/a n/a n/a
2021-11-15 2021-09-30 13F ABCELLERA BIOLOGICS Cmn Put 118,500 -39.63 2,375 -45.01 n/a n/a n/a
2021-08-16 2021-06-30 13F ABCELLERA BIOLOGICS COM Put 196,300 1,119.25 4,319 689.58 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ABCELLERA BIOLOGICS COM Put 16,100 547 n/a n/a n/a
2021-05-17 2021-03-31 13F ABCELLERA BIOLOGICS COM Put 16,100 547 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.